GlassScriptPhysician profile
Jennifer Lira
NPI 1720475973
$1,145.34
in general payments reported to CMS, 2019-2025
17 companies · $254 in 2025
The $254 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $501 · 2020: $28.90 · 2021: $93.67 · 2022: $18.83 · 2023: $156 · 2024: $93.08 · 2025: $254.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $503.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $502.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $243.09 | 2019-2023 | |
| Alcon Vision LLC | $131.66 | 2019-2025 | Clareon, Unity |
| Sight Sciences, INC. | $121.64 | 2025 | Omni Surgical System, Sion Surgical Instrument |
| Johnson & Johnson Surgical Vision, INC. | $119.83 | 2019 | |
| Eyepoint US, INC. | $90.15 | 2019 | |
| Thea Pharma INC. | $57.79 | 2023-2025 | Iyuzeh |
| Kala Pharmaceuticals, INC. | $56.65 | 2019-2021 | |
| Coopervision INC. | $56.42 | 2024 | Myday Contact Lens |
| Abbvie INC. | $41.08 | 2023 | |
| Notal Vision, INC. | $40.69 | 2025 | Foresee Home |
| Rxsight INC | $36.66 | 2024 | Rxsight Contact Lens, Rxsight Injector Cartridge, Light Adjustable Lens (Lal) |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $34.93 | 2021 | |
| Sun Pharmaceutical Industries INC. | $28.39 | 2020-2021 | |
| Rayner Intraocular Lenses Limited | $26.47 | 2023 | Omidria, Rayone Spheric, Rayone Emv |
| Aerie Pharmaceuticals, INC. | $22.19 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec USA, INC. | $18.88 | 2023 | Veracity Surgical |
| Ivantis, INC | $18.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Lira listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.